Comparison of the fibrinolytic response to desmopressin acetate (DDAVP) infusion versus venous occlusion in patients with coronary artery disease.
A 20-min venous occlusion and a desmopressin acetate (DDAVP, 0.4 microgram.Kg-1, 15 min) infusion test have been compared to evaluate fibrinolytic capacity in proven coronary artery disease. Basal values of plasma tissue plasminogen activator (t-PA) activity and antigen and of t-PA inhibitor (PAI) were normally distributed in this patient group. However, after both stimuli, highly significant (P less than 0.005) increases of t-PA antigen and activity have been observed. Renormalization of t-PA levels after DDAVP infusion occurred more rapidly for antigen (120 min) than for activity concentrations (greater than 240 min). A DDAVP infusion test seems more appropriate for evaluation of the fibrinolytic capacity as the induced decrease in PAI level was significant (P less than 0.005) and lasted for at least 240 min, while it was not significant for the venous occlusion test.
Duprez
D
D
Department of Cardiology-Angiology, University Hospital, Ghent, Belgium.
Baele
G
G
De Buyzere
M
M
Vandenbroecke
P
P
Clement
D L
DL
D001132:Arm / Q000098:blood supply*; D003327:Coronary Disease / Q000097:blood*; D003894:Deamino Arginine Vasopressin / Q000494:pharmacology*; D006801:Humans; D007263:Infusions, Parenteral; D008875:Middle Aged; D010959:Tissue Plasminogen Activator / Q000037:antagonists & inhibitors / Q000097:blood*; D014111:Tourniquets
D010959:Tissue Plasminogen Activator; D003894:Deamino Arginine Vasopressin